期刊文献+

CPAP治疗对OSAHS患者血清8-isoprostane、8-OHdG水平的影响 被引量:2

Effect of CPAP therapy on serum level of 8-isoprostane and 8-OHdG in patients with OSAHS
下载PDF
导出
摘要 目的观察OSAHS患者一夜CPAP治疗后血清8-isoprostane、8-OHdG的水平变化。方法选择经PSG检查确诊的OSAHS患者10例纳入治疗组(OSAHS组)及非OSASH患者10例纳入正常对照组(非OSAHS组),(1)比较OSAHS患者与非OSAHS患者血清8-isoprostane、8-OHdG水平差异;(2)治疗组给予夜间CPAP干预,对照比较患者予以CPAP治疗的前后血清中8-isoprostane、8-OHdG水平的变化。结果 (1)OSAHS组血清8-isoprostane、8-OHdG均高于非OSAHS组(P<0.05);(2)10例OSAHS患者经1晚CPAP治疗后血清8-isoprostane、8-OHdG水平较治疗前无显著变化(P>0.05)。结论在OSAHS患者体内存在氧化应激反应,短期的CPAP治疗对此反应无改善作用,需进行长期CPAP治疗。 Objective To observe thechanges of serum8-isoprostaneand serum 8-OHdGlevels in patientswith OSAHS,and to compare the effect of CPAP intervention on the above indexes after the treatment of OSAHS.Methods 10 non-OSASH patients were taken as the control group and 10 patients with OSAHS diagnosed by PSGas the experimental group.(1) The difference of serum 8-isoprostane and 8-OHdG levels was comcontrol group and the experimental group.(2)The experimental group was treated witli 1 night ence of serum 8-isoprostane and 8-OHdG levels prior treatment and post-treatment was compared. Results ① Theserum 8-isoprostane and 8-OHdG in the experimental group were higher thian those in the control group (P 〈0. 0 5 ) .② After 1 night treatment,serum 8-isoPG and 8-OHdG of 10 cases of OSAHS patients had no statistical significant difference than before (P〉0. 05). Conclusion Oxidative stress occurs in OSAHS patients,of 1 night has no effect on it and it needs long term therapy.
出处 《临床肺科杂志》 2017年第12期2141-2143,共3页 Journal of Clinical Pulmonary Medicine
基金 昆明医科大学研究生创新基金(No 2016S32)
关键词 OSAHS 持续气道正压通气 氧化应激 OSAHS continuous positive airway pressure oxidative stress
  • 相关文献

参考文献3

二级参考文献18

  • 1张文华,郭智勇,张文萍,肖本泓.阻塞性睡眠呼吸暂停低通气综合征临床分析[J].河北医药,2007,29(4):323-324. 被引量:11
  • 2Cooke MS,Evans MD,Dizdaroglu M,et al.Oxidative DNA damage:mechanisms,mutation,and disease.FASEB J,2003,17:1195-1214.
  • 3Schulz R,Mahmoudi S,Hattar K,et al.Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea:impact of continuous positive airway pressure therapy.Am J Respir Crit Care Med,2000,162:566-570.
  • 4Christou K,Moulas AN,Pastaka C,et al.Antioxidant capacity in obstructive sleep apnea patients.Sleep Med,2003,4:225-228.
  • 5Carpagnano GE,Kharitonov SA,Resta O,et al.8-Isoprostane,a marker of oxidative stress,is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy.Chest,2003,124:1386-1392.
  • 6Lavie L,Vishnevsky A,Lavie P.Evidence for lipid peroxidation in obstructive sleep apnea.Sleep,2004,27:123-128.
  • 7Yamauchi M,Nakno H,Moekawa J,et al.Oxidative Stress in Obstructive Sleep Apnea.Chest,2005,127:1674-1679.
  • 8Ohisa N,Ogawa H,Murayama N,et al.A novel EEG index for evaluating the sleep quality in patients with obstructive sleep apnea-hypopnea syndrome[J].Tohoku J Exp Med 2011,223 (4):285-289.
  • 9Marti S,Sampol G,Munoz X,et al.Mortality in severe sleep apnoea/hypopnoea syndrome patients:impact of treatment[J].Eur Respir J 2002,20:1511-1518.
  • 10Sariman N,Levent E,Aksungar FB,et al.Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome[J].Respiration,2010,79(1):38-45.

共引文献245

同被引文献23

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部